 |
 |
|
|
RESÚMENES ABRIL 2006 |
Basic Neuroscience
& Pharmacology
(Haga un click en la información del journal
para acceder al resúmen)
Generalist
genes and cognitive neuroscience
Lee M Butcher, Joanna KJ Kennedy and Robert Plomin
Current Opinion in Neurobiology. Volume 16, Issue 2, April 2006, Pages 145-151
The
cognitive neuroscience of remote episodic, semantic and spatial memory
Morris Moscovitch, Lynn Nadel, Gordon Winocur, Asaf Gilboa and R Shayna Rosenbaum
Current Opinion in Neurobiology. Volume 16, Issue 2, April 2006, Pages 179-190
Uniquely
human social cognition
Rebecca Saxe
Current Opinion in Neurobiology. Volume 16, Issue 2, April 2006, Pages 235-239
Investigation
of the SSRI augmentation properties of 5-HT2 receptor antagonists
using in vivo microdialysis
Laura J. Boothman, Stephen N. Mitchell and Trevor
Sharp
Neuropharmacology. Volume 50, Issue 6, May 2006, Pages 726-732
Effect
of the attention deficit/hyperactivity disorder drug atomoxetine
on extracellular concentrations of norepinephrine and dopamine in several brain regions of the
rat
Neuropharmacology. Volume 50, Issue 6, May 2006, Pages 755-760
Statin use and the risk of Alzheimer’s disease: The MIRAGE Study
Robert C. Green, Sally E. McNagny,
Parimala Jayakumar, L.
Adrienne Cupples, Kelly Benke,
Lindsay A. Farrer and MIRAGE Study Group
Alzheimer's and Dementia. Volume 2, Issue 2, April 2006, Pages 96-103
Potentially
modifiable risk factors for dementia in identical twins
Margaret Gatz, James A.
Mortimer, Laura Fratiglioni, Boo Johansson, Stig Berg, Chandra A. Reynolds and Nancy L. Pedersen
Alzheimer's and Dementia. Volume 2, Issue 2, April 2006, Pages 110-117
Do
cholinergic therapies have disease-modifying effects in Alzheimer’s disease?
Marwan N. Sabbagh, Martin R. Farlow,
Alzheimer's and Dementia. Volume 2, Issue 2, April 2006, Pages 118-125
Risperidone-related
Weight Gain: Genetic and Nongenetic Predictors
Lane, Hsien-Yuan;
Liu, Yi-Ching; Huang, Chieh-Liang;
Chang, Yue-Cune; Wu, Po-Lun;
Lu, Chung-Ta; Chang, Wen-Ho
Journal of Clinical
Psychopharmacology. 26(2):128-134,
April 2006
Time Course of In Vivo 5-HTT Transporter Occupancy
by Fluvoxamine
Takano, Akihiro; Suhara, Tetsuya; Ichimiya,
Tetsuya; Yasuno, Fumihiko;
Suzuki, Kazutoshi
Journal of Clinical Psychopharmacology. 26(2):188-191, April 2006
David M. Amodio and Chris D. Frith
Nature Reviews Neuroscience 7, 268-277 (April 2006)
Polymorphisms in the 5-Hydroxytryptamine 2A
Receptor and CytochromeP4502D6 Genes Synergistically Predict Fluvoxamine-Induced Side Effects in Japanese Depressed
Patients
Yutaro Suzuki, Kazushi Sawamura and Toshiyuki Someya
Neuropsychopharmacology (2006) 31,
825-831
Neuronal Tryptophan Hydroxylase mRNA Expression in the Human Dorsal and Median Raphe Nuclei: Major Depression and Suicide
Helene Bach-Mizrachi, Mark D Underwood, Suham
A Kassir, Mihran J Bakalian, Etienne Sibille,
Hadassah Tamir, J John Mann and Victoria Arango
Neuropsychopharmacology (2006) 31,
814-824
Long-Term Treatment of Rats with Haloperidol:
Lack of an Effect on Brain N-Acetyl Aspartate Levels
Juan Bustillo,
Ranee Barrow, Rodrigo Paz, Jennifer Tang, Navid Seraji-Bozorgzad, Gregory J
Moore, Federico Bolognani, John Lauriello,
Nora Perrone-Bizzozero and Matthew P Galloway
Neuropsychopharmacology (2006) 31,
751-756
Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
Nature Neuroscience 9, 519 - 525
(2006)
B Bondy, A Buettner and P Zill
Molecular
Psychiatry (2006) 11, 336–351
Modulation of
adult hippocampal neurogenesis
by thyroid hormones: implications in depressive-like behavior
A Montero-Pedrazuela, C Venero,
R Lavado-Autric, I Fernández-Lamo, J M García-Verdugo,
J Bernal and A Guadaño-Ferraz
Molecular Psychiatry (2006)
11, 361–371
Prototypical
antipsychotic drugs protect hippocampal neuronal cultures against cell death
induced by growth medium deprivation
BMC Neuroscience 2006, 7:28;
30 March 2006
Cumulative Effect of COMT and 5-HTTLPR Polymorphisms and Their Interaction With Disease Severity and Comorbidities on the Risk of Psychosis in Alzheimer Disease
Barbara Borroni, Mario Grassi, Chiara
Agosti, Silvana Archetti, Chiara Costanzi, Cristina Cornali, Carlo Caltagirone,
Luigi Caimi, Monica Di Luca, and Alessandro Padovani
Am J Geriatr Psychiatry
14:343-351, April 2006
In rats chronically treated with clozapine, tyrosine depletion attenuates the clozapine-induced in vivo increase in prefrontal cortex
dopamine and norepinephrine levels
George E. Jaskiw, Bobbi Kirkbride and
Rodolfo Bongiovanni
Psychopharmacology
2006; Volume 185, Number 4: 416 - 422
Dose-dependent retrograde facilitation of verbal
memory in healthy elderly after acute oral lorazepam
administration
Nunzio Pomara,
Thomas M. Facelle, Amy E. Roth,
Lisa M. Willoughby, David J. Greenblatt
and John J. Sidtis
Psychopharmacology
2006; Volume 185, Number 4: 487 - 494
Julia M.
Lappin, Kevin Morgan, Craig Morgan, Gerard Hutchison,
Xavier Chitnis, John Suckling, Paul Fearon, Philip K. McGuire, Peter B. Jones, Julian Leff, Robin M. Murray and Paola Dazzan
Schizophrenia Research. Volume 83, Issues 2-3, April 2006, Pages 145-153
Eric Vermetten, Christian Schmahl, Sanneke Lindner, Richard
J. Loewenstein, and J. Douglas Bremner
American Journal of Psychiatry 163:630-636, April 2006
Corticotropin-Releasing
Factor Receptor Antagonists in Affective Disorders and Drug Dependence - An
Update
Steckler, Thomas; Dautzenberg, Frank
M.
CNS & Neurological Disorders - Drug Targets,
Volume 5, Number 2, April 2006, pp. 147-165(19)
Landgraf, Rainer
CNS & Neurological Disorders - Drug Targets,
Volume 5, Number 2, April 2006, pp. 167-179(13)
Carvajal, C.; Dumont,
Y.; Quirion, R.
CNS & Neurological Disorders - Drug Targets,
Volume 5, Number 2, April 2006, pp. 181-195(15)
Gastrin-Releasing
Peptide Receptor as a Molecular Target for Psychiatric and Neurological
Disorders
Roesler, R.; Henriques, J. A.P.; Schwartsmann, G.
CNS & Neurological Disorders - Drug Targets,
Volume 5, Number 2, April 2006, pp. 197-204(8)
Reinscheid, Rainer K
CNS & Neurological Disorders - Drug Targets,
Volume 5, Number 2, April 2006, pp. 219-224(6)
Holmes, A.; Picciotto,
M. R
CNS & Neurological Disorders - Drug Targets,
Volume 5, Number 2, April 2006, pp. 225-232(8)
Mood
changes correlate to changes in brain serotonin precursor trapping in women
with premenstrual dysphoria
Olle Eriksson, Anders Wall, Ina Marteinsdottir, Hans Ågren, Per Hartvig, Gunnar Blomqvist, Bengt Långström and Tord Naessén
Psychiatry Research: Neuroimaging.
Volume 146, Issue 2, 31 March 2006, Pages 107-116
A
magnetic resonance spectroscopy investigation of obsessive–compulsive disorder
and anxiety
Stephen
P. Whiteside,
Psychiatry Research: Neuroimaging.
Volume 146, Issue 2, 31 March 2006, Pages 137-147
Comparative Absorption Profiles of Divalproex Sodium Delayed-Release Versus Extended-Release Tablets—Clinical Implications
Sandeep Dutta, Ronald C Reed, Robert F O'Dea
The Annals of
Pharmacotherapy: Vol. 40, No. 4, pp. 619-625
Endophenotypes
Successfully Lead to Gene Identification: Results from the Collaborative Study
on the Genetics of Alcoholism
Danielle M. Dick,
Kevin Jones, Nancy Saccone, Anthony Hinrichs, Jen C. Wang, Alison Goate, Laura Bierut,
Laura Almasy, Marc Schuckit,
Victor Hesselbrock, Jay Tischfield,
Tatiana Foroud, Howard Edenberg,
Bernice Porjesz and Henri Begleiter
Behavior
Genetics 2006; Volume 36, Number 1: 112 - 126
Clozapine Modulates Aromatic L-Amino Acid Decarboxylase
Activity in Mouse Striatum
Norton H. Neff, Trina A. Wemlinger,
Anne-Marie Duchemin, and Maria Hadjiconstantinou
Interaction with Sigma1 Protein, but Not N-Methyl-D-aspartate
Receptor, Is Involved in the Pharmacological Activity of Donepezil
Tangui Maurice,
Johann Meunier, Bihua Feng, John Ieni, and Daniel T.
Monaghan
Differential
effects of classical neuroleptics and a newer
generation antipsychotics on the MK-801 induced behavioural primitivization in
mouse
Marie
Nilsson, Katarina Rydén Markinhuhta and Maria L. Carlsson
TNFα
Signaling in Depression and Anxiety: Behavioral Consequences of Individual
Receptor Targeting
Birgitte B. Simen,
Catharine H. Duman, Arthur A. Simen
and Ronald S. Duman
Biological Psychiatry. Volume 59, Issue 9, 1 May 2006, Pages 775-785
Antidepressant
Drug Treatment Modifies the Neural Processing of Nonconscious
Threat Cues
Catherine
J. Harmer, Clare E. Mackay, Catriona B. Reid, Philip
J. Cowen and Guy M. Goodwin
Biological Psychiatry. Volume 59, Issue 9, 1 May 2006, Pages 816-820
Lithium and inositol:
effects on brain water homeostasis in the rat
P. Phatak, A. Shaldivin,
L. S. King, P. Shapiro and W. T. Regenold
Psychopharmacology
2006; Volume 186, Number 1: 41 - 47
Adaptive and maladaptive impulsivity, platelet
monoamine oxidase (MAO) activity and risk-admitting
in different types of risky drivers
Marika Paaver, Diva Eensoo, Aleksander Pulver and
Jaanus Harro
Psychopharmacology
2006; Volume 186, Number 1: 32 - 40
Increased frontal and paralimbic
activation following ayahuasca, the pan-amazonian inebriant
Jordi Riba,
Sergio Romero, Eva Grasa, Esther Mena, Ignasi Carrió and Manel J. Barbanoj
Psychopharmacology
2006; Volume 186, Number 1: 93 - 98
Serum
brain-derived neurotrophic factor is decreased in
bipolar disorder during depressive and manic episodes
Angelo
B.M. Cunha, Benicio N. Frey, Ana C. Andreazza, Júlia D. Goi, Adriane R. Rosa, Carlos A. Gonçalves,
Aida Santin and Flavio Kapczinski
Neuroscience Letters. Volume 398, Issue 3, 8 May 2006, Pages 215-219
Andreas Meyer-Lindenberg, Joshua
W. Buckholtz, Bhaskar Kolachana, Ahmad R. Hariri, Lukas Pezawas,
Giuseppe Blasi, Ashley Wabnitz,
Robyn Honea, Beth Verchinski, Joseph H. Callicott, Michael Egan, Venkata
Mattay, and Daniel R. Weinberger
PNAS | April 18, 2006 | vol. 103 | no. 16 | 6269-6274
R P Ebstein
Molecular Psychiatry (2006)
11, 427–445
The catechol-O-methyl transferase
(COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons
Molecular
Psychiatry (2006) 11, 446–458
The Striatal and Extrastriatal D2D3 Receptor-Binding Profile of Clozapine in Patients with Schizophrenia
Gerhard Gründer,
Christian Landvogt, Ingo Vernaleken,
Hans-Georg Buchholz, Jasmin Ondracek,
Thomas Siessmeier, Sebastian Härtter,
Mathias Schreckenberger, Peter Stoeter,
Christoph Hiemke, Frank Rösch, Dean F Wong and Peter Bartenstein
Neuropsychopharmacology (2006) 31,
1027-1035
Decreased
striatal D1 binding as measured using PET and [11C]SCH 23,390 in patients with major depression with anger
attacks
Darin D.
Dougherty, Ali A. Bonab, William E. Ottowitz, Eli Livni, Nathaniel M.
Alpert, Scott L. Rauch, Maurizio Fava, Alan J. Fischman
Depression
and Anxiety 23:175-177, 2006
Expression
of noradrenergic α1, serotoninergic 5HT2a and dopaminergic D2 receptors on
neurons activated by typical and atypical antipsychotic drugs
Jianyi Ma, Nancy Ye and Bruce M. Cohen
Murad Atmaca, Ayşe Aydin, Ertan Tezcan, A. Kursad Poyraz and Bilge
Kara
Sub-chronic
antipsychotic drug treatment does not alter brain phospholipid
fatty acid composition in rats
Beth
Levant, Jennifer F. Crane and Susan E. Carlson